ID: ALA2402936

Max Phase: Preclinical

Molecular Formula: C27H34N8O6S

Molecular Weight: 598.69

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)[C@@H]1CNC(=S)NC[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N1

Standard InChI:  InChI=1S/C27H34N8O6S/c28-18(10-16-6-8-17(36)9-7-16)24(39)35-21-13-32-27(42)31-12-20(23(29)38)34-26(41)19(11-15-4-2-1-3-5-15)33-22(37)14-30-25(21)40/h1-9,18-21,36H,10-14,28H2,(H2,29,38)(H,30,40)(H,33,37)(H,34,41)(H,35,39)(H2,31,32,42)/t18-,19-,20-,21+/m0/s1

Standard InChI Key:  MNTOUKHSDQFMMF-XSDIEEQYSA-N

Associated Targets(non-human)

Kappa opioid receptor 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3127 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 3620 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 6060 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 3911 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 598.69Molecular Weight (Monoisotopic): 598.2322AlogP: -2.96#Rotatable Bonds: 7
Polar Surface Area: 229.80Molecular Species: NEUTRALHBA: 8HBD: 9
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.47CX Basic pKa: 7.73CX LogP: -2.32CX LogD: -2.68
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.15Np Likeness Score: 0.61

References

1. Touati-Jallabe Y, Bojnik E, Legrand B, Mauchauffée E, Chung NN, Schiller PW, Benyhe S, Averlant-Petit MC, Martinez J, Hernandez JF..  (2013)  Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations.,  56  (14): [PMID:23822516] [10.1021/jm4008592]
2. Touati-Jallabe Y, Bojnik E, Legrand B, Mauchauffée E, Chung NN, Schiller PW, Benyhe S, Averlant-Petit MC, Martinez J, Hernandez JF..  (2013)  Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations.,  56  (14): [PMID:23822516] [10.1021/jm4008592]

Source